Home oxygen therapy in COPD patients. Results from the Danish Oxygen Register 1994-2000

Danish Medical Bulletin

Volumn 53, Issue 3, 2006, Pages 310-325

  Ringbaek, Thomas Joergen ^a,b  

^a Mental Health Services CPH   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN; STEROID;

ARTERIAL OXYGEN SATURATION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DENMARK; DISEASE SEVERITY; DYSPNEA; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOME CARE; HOSPITALIZATION; HUMAN; HYPERCAPNIA; HYPOXEMIA; MEDICAL DOCUMENTATION; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT CARE; OXYGEN THERAPY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTAL MAIL; PRACTICE GUIDELINE; PREDICTION; PRESCRIPTION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SLEEP; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DENMARK; FEMALE; HEALTH PLANNING GUIDELINES; HOME CARE SERVICES, HOSPITAL-BASED; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; SMOKING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747660264     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Ringbaek T, Lange P, Viskum K. Compliance with LTOT and consumption of mobile oxygen. Respir Med 1999; 93: 333-7.
2. Ringbaek TJ, Lange P, Viskum K. Geographic variation in long-term oxygen therapy in Denmark: factors related to adherence to guidelines for long-term oxygen therapy. Chest 2001; 119: 1711-6.
3. Ringbaek TJ, Lange P, Viskum K. Are patients on long-term oxygen therapy followed up properly? Data from the Danish Oxygen Register. J Intern Med 2001; 250: 131-6.
4. Ringbaek TJ, Viskum K, Lange P. Non-continuous home oxygen therapy: utilization, symptomatic effect and prognosis, data from a national register on home oxygen therapy. Respir Med 2001; 95(12): 980-5.
5. Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic COPD? Eur Respir J 2002; 20: 38-42.
6. Ringbaek TJ, Viskum K, Lange P. BMI and oral glucocorticoids as predictors of prognosis in COPD patients on LTOT. Chronic Respiratory Disease 2004; 1(2): 71-8.
7. Ringbaek TJ, Fabricius P, Lange P. The effect of home oxygen therapy on hospitalization in moderate hypoxaemic COPD. Chronic Respiratory Disease 2005; 2: 107-8.
8. Ringbaek TJ, Lange P. The impact of The Danish Oxygen Register on patients' characteristics, treatment modalities, outcomes, and quality of domiciliary oxygen therapy. Respir Med 2006; 100(2): 218-225.
9. Barach AL. The therapeutic use of oxygen. JAMA 1922; 79: 693-9.
10. Nocturnal Oxygen Therapy trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980; 93: 391-8.
11. Medical Research Council Working Party. Report of long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-6.
12. O'Donohue WJ Jr. Indications for long-term oxygen therapy and appropriate use. In: Walter J. O'Donohue, Jr., Editor. Long-term oxygen therapy. Scientific basis and clinical application. New York, Dekker, 1995: 53-68.
13. O'Donohue WJ Jr. Home oxygen therapy. Clin Chest Med 1997; 18: 535-45.
14. Górecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997; 52: 674-9.
15. Ström K, Boe J. A national register for long-term oxygen therapy in chronic hypoxia: preliminary results. Eur Respir J 1988; 1: 952-8.
16. Pépin J-L, Barjhoux CE, Deschaux C, Brambilla C on behalf of the ANTADIR Working Group on Oxygen Therapy. Long-term oxygen therapy at home. Chest 1996; 109: 1144-50.
17. Granados A, Escarrabill J, Borràs JM, Rodriguez-Roisin R. The importance of process variables analysis in the assessment of long-term oxygen therapy by concentrator. Respir Med 1997; 91: 89-93.
18. Kampelmacher MJ, Kersteren RG, Alsbach GPJ, Melissant CF, Wynne HJ, Douze JM, Lammers JW. Prescription and usage of long-term-oxygen therapy in patients with chronic obstructive pulmonary disease in the Netherlands. Respir Med 1999; 93: 46-51.
19. Dilworth JP, Higgs CMB, Jones PA, White RJ. Prescription of oxygen concentrators: adherence to published guidelines. Thorax 1989; 44: 576-8.
20. Bellone A, Venanzi D, De Angelis G, Adone R, Aliprandi P, Castelli C, Raineri M. Who should prescribe long-term oxygen in patients affected by chronic arterial hypoxaemia? Monaldi Arch Chest Dis 1994; 49(5): 396-8.
21. Waterhouse JC, Nichol J, Howard P. Survey on domiciliary oxygen by concentrator in England and Wales. Eur Resp J 1994; 7: 2021-5.
22. Walshaw MJ, Lim R, Evans CC, Hind CR. Prescription of oxygen concentrators for long term oxygen treatment: reassessment in one district. BMJ 1988; 297:1030-2.
23. Restrick LJ, Paul EA, Braid GM, Cullinan P, Moore-Gillon J, Wedzicha JA. Assessment and follow up of patients prescribed long term oxygen treatment. Thorax 1993; 48: 708-13.
24. Morrison D, Skwarski K. MacNee W. Review of the prescription of domiciliary long term oxygen therapy in Scotland. Thorax 1995; 50: 1103-5.
25. Zielinski J, Sliwinsky, Tobiasz M, Gorecka D. Long-term oxygen therapy in Poland. Monaldi Arch Chest Dis 1993; 48: 479-80.
26. Okubadejo AA, Paul EA, Wedzicha JA. Domiciliary oxygen cylinders: indications, prescription and usage. Respir Med 1994; 88: 777-85.
27. Cranston JM, Nguyen A-M, Crockett AJ. The relative survival of COPD patients on long-term oxygen therapy in Australia: A comparative study. Respirology 2004; 9: 237-42.
28. Chailleux E, Laaban J-P, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy. Data from the ANTADIR observatory. Chest 2003; 123: 1460-6.
29. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Enrhart M, Schott R, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos Santos J. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999: 14: 1002-8.
30. ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-S120.
31. Restrick LJ, Davies SW, Noone L, Wedzicha JA. Ambulatory oxygen in chronic heart failure. Lancet 1992; 340(8829): 1192-3.
32. Waterhouse JC, Howard P. Breathlessness and portable oxygen in chronic obstructive airways disease. Thorax 1983; 38: 302-6.
33. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000; 55: 539-43.
34. Killen JWW, Corris PA. A pragmatic assessment of the placement of oxygen when given for exercise induced dyspnoea. Thorax 2000; 55: 544-6.
35. Liss HP, Grant BJB. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 137: 1285-8.
36. Roberts CM, Bell J, Wedzicha JA. Comparison of the efficacy of a demand oxygen delivery system with continuous low flow oxygen in subjects with stable COPD and severe oxygen desaturation on walking. Thorax 1996; 51: 831-4.
37. Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in "pink puffers". Lancet 1981: i: 907-9.
38. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxaemia. Am J Respir Crit Care Med 1995; 152: 1616-9.
39. Chailleux E, Fauroux B, Binet F, Dautzenberg B, Polu JM for the Observatory Group of ANTADIR. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR observatory. Chest 1996; 109: 741-9.
40. Pallisgaard G, Petersen JT, Viskum, K. Dansk Lungemedicinsk Selskabs rekommandation. Iltbehandling i hjemmet ved kronisk respirationsin-sufficiens. Ugeskr Læger 1988; 150: 3206 (in Danish).
41. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995; 8(8):1398-420.
42. BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. Thorax 1997; 52(5 suppl): 1S-27S.
43. Wedzicha JA. Domiciliary oxygen therapy services: clinical guidelines and advice for prescribers. J R Coll Physicians Lond 1999; 33: 445-7.
44. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS on behalf of the GOLD Scientific Committee. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiatives for chronic obstructive lung disease (GOLD). Am J Respir Crit Care Med 2001; 163: 1256-76 (www.GOLD.com).
45. Young IH, Crockett AJ, McDonald CF. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. MJA 1998; 168: 21-5.
46. Canadian Thoracic Society Workshop Group. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 1992; 147:420-8.
47. Russi EW, Leuenberger P, Brändli O, Frey JG, Grebski E, Gugger M, Paky A, Pons M, Karrer W, Kuhn M, Rochat T, Schibli R, Soler M, Wacker J. Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. Swiss M Wkly 2002; 132: 67-78.
48. Zielinski J. Indications for long-term oxygen therapy: a reappraisal. Monaldi Arch Chest Dis 1999; 54: 178-82.
49. Escarrabill J, Estopa R, Huguet M, Manresa F. Domiciliary oxygen therapy. Lancet 1985; 2: 779.
50. Brougher LI, Blackwelder AK, Grossman GD, Staton GW Jr. Effectiveness of medical necessity guidelines in reducing cost of oxygen therapy. Chest 1986; 90: 646-8.
51. Veale D, Chailleux E, Taytard A, Cardinaud JP. Characteristics and survival of patients prescribed long-term oxygen therapy outside prescription guidelines. Eur Respir J 1998; 12: 780-784.
52. Baudouin SV, Waterhouse JC, Tahtamouni T, Smith JA, Baxter J, Howard, P. Long term domiciliary oxygen treatment for chronic respiratory failure reviewed. Thorax 1990; 45: 195-8.
53. Ström K, Boe J, Boman G, Midgren B, Rosenhall L. Long-term domiciliary oxygen therapy. Experiences acquired from the Swedish oxygen register. Monaldi Arch Chest Dis 1993; 48: 473-8.
54. Górecka D, Sliwinski P, Zielinski J. Adherence to entry criteria and one year experience of long-term oxygen therapy in Poland. Eur Respir J 1992; 5: 848-52.
55. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J 2001; 31: 448-54.
56. Frey IG, Kaelin RM, De Werra M, Jordan B, Tschopp JM. Continuous oxygen therapy at home. Observations of oxygen users after an instruction program. Rev Mal Respir 1992; 9: 301-5.
57. Peckham DG, McGibbon K, Tonkinson J, Plimbley G, Pantin C. Improvement in patient compliance with long-term oxygen therapy following formal assessment with training. Respir Med 1998; 92: 1203-6.
58. Atis S, Tutluoglu B, Bugdayci R. Characteristics and compliance of patients receiving long-term oxygen therapy (LTOT) in Turkey. Monaldi Arch Chest Dis 2001; 56: 105-9.
59. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med 2004; 98(4): 285-93.
60. Katsenos S, Froudarakis ME, Charisis A, Vassiliou M P, Constantopoulos SH. Long-term oxygen theray in Loannina. Respiration 2004; 71: 619-624.
61. Shankar P, Muthiah MM. Audit on prescription of long-term oxygen treatment. Clin Perform Qual Health Care 2000; 8: 134-5.
62. Guyatt GH, McKim DA, Austin P, Bryan R, Norgren J, Weaver B, Goldstein RS. Appropriateness of domiciliary oxygen delivery. Chest 2000; 118: 1303-8.
63. Tzanakis N, Bouros D, Mamatzakis P, Samiou M, Siafakas NM. Long-term oxygen therapy on the island of Crete, Greece. Monaldi Arch Chest Dis 1998; 53(5): 533-6.
64. Oba Y, Salzman GA, Willsie SK. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Respir Care 2000; 45: 401-6.
65. Crockett AJ, Cranston JM, Moss JR, Alpers JH. A review of long-term oxygen therapy for chronic obstructive pulmonary disease. Respir Med 2001; 95: 437-43.
66. Drug Tariff: Introduction of Oxygen Concentrators to the Domiciliary Oxygen Therapy Service. London Department of Health and Social Security, 1986, Publ No FPN 398.
67. Petty TL, Casaburi R. Recommendations of the fifth Oxygen Consensus Conference. Respir Care 2000; 45: 957-61.
68. Silverman BG, Gross TP, Babish JD. Home oxygen therapy in Medicare beneficiaries, 1991 and 1992. Chest 1997; 112:380-6.
69. Eaton TE, Grey C, Garrett JE. An evaluation of short-term oxygen therapy: the prescription of oxygen to patients with chronic lung disease hypoxic at discharge from hospital. Respir Med 2001; 95: 582-7.
70. Chaney JC, Jones K, Grathwohl K, Olivier KN. Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy. Chest 2002; 122: 1661-7.
71. Levi-Valensi P, Weitzenblum E, Pedinielli J-L, Racineux JL, Duwoos H. Three-month follow-up of arterial blood gas determinations in candidates for long-term oxygen therapy. Am Rev Respir Dis 1986; 133: 547-51.
72. Timms RM, Kvale PA, Anthonisen NR, Boylen CT, Cugell DW, Petty TL, Williams GW. Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapy. JAMA 1981; 245: 2514-5.
73. Andersson I, Johansson K, Larsson S, Pehrsson K. Long-term oxygen therapy and quality of life in elderly patients hospitalised due to severe exacerbation of COPD. A 1 year follow-up study. Respir Med 2002; 96(11): 944-9.
74. Rahman S, Howard P. Natural history of arterial hypoxaemia in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1993; 48: 395-8.
75. O'Donohue WJ Jr. Effect of oxygen therapy on increasing arterial oxygen tension in hypoxemic patients with stable chronic obstructive pulmonary disease while breathing ambient air. Chest 1991; 100: 968-72.
76. Cottrell JJ, Openbrier D, Lave JR, Paul C, Garland JL. Home oxygen therapy. A comparison of 2- vs 6-month patient reevaluation. Chest 1995; 107:358-61.
77. Zielinski J. A nationwide system of long-term oxygen therapy: the Polish experience Respir Care 2000; 45: 231-5.
78. Clini E, Vitacca M, Foglio K, Simoni P, Ambrosino N. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J 1996; 9: 1605-10.
79. Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F. Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy. Chest 2001; 119: 364-9.
80. Pehrsson K, Frostrom E, Larsson S, Skoogh BE. Improved quality of ambulatory health care of patients treated with oxygen for long period. Lakartidningen 1987; 84(34): 2578-80 (in Swedish).
81. Zielinski J. Long-term oxygen therapy in conditions other than chronic obstructive pulmonary disease. Respir Care 2000; 45: 172-6.
82. Ström K, Boman G. Long-term oxygen therapy in parenchymal lung diseases: an analysis of survival. The Swedish Society of Chest Medicine. Eur Respir J 1993; 6: 1264-70.
83. Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst Rev 2001; 3: CD002883
84. Zinman R, Corey M, Coates AL, Canny GJ, Connolly J, Levison H, Beaudry PH. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr 1989; 114: 368-77.
85. Jackson M, Shneerson J. An evaluation of the use of concentrators for domiciliary oxygen supply for less than 8 h day-1. Respir Med 1998; 92(2): 250-5.
86. Viskum K. Organisation of professional care services with special reference to LTOT. Monaldi Arch Chest Dis 1993; 48(5): 453-7.
87. Ström K, Olofsson J, Skoogh B.-E. Current status of home oxygen therapy in Sweden. In: Kira S, Petty TL, eds. Progress in domiciliary respiratory care. Current status and perspective. Amsterdam, Elsevier Science B.V. 1994; 71-8.
88. Muir JF, Voisin C, Ludot A. Organization of home respiratory care: the experience in France with ANTADIR. Monaldi Arch Chest Dis 1993; 48(5): 462-7.
89. Ström K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Med 1993; 147(3): 585-91.
90. Aida A, Miyamoto K, Nishimura M, Aiba M, Kira S, Kawakami Y, and the Respiratory Failure Research Group in Japan. Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy. Am J Respir Crit Care Med 1998; 158: 188-93.
91. Donner CF, Braghiroli A, Zaccaria S, Erbetta M, Ioli F. Current status of home oxygen therapy in Italy. In: Kira S, Petty TL, Eds. Progress in Domiciliary respiratory care. Current status and perspective. Amsterdam, Elsevier Science B.V., 1994; 35-40.
92. Rahman S, Howard P. Home oxygen in the United Kingdom. In: Kira S, Petty TL, Eds. Progress in Domiciliary respiratory care. Current status and perspective. Amsterdam, Elsevier Science B.V., 1994; 87-91.
93. Schaanning J, Ström K, Boe J. Do patients using long-term liquid oxygen differ from those on traditional treatment with oxygen concentrators and/or compressed gas cylinders? A comparison of two national registers. Respir Med 1998; 92(1): 84-7.
94. Kampelmacher MJ, van Kestern RG, Alsbach GP, Melissant CF, Wynne HJ, Douze JM, Lammers JW. Characteristics and complaints of patients prescribed long-term oxygen therapy in The Netherlands. Respir Med 1998; 92(1): 70-5.
95. Vergeret J, Brambilla C, Mounier L. Portable oxygen therapy: use and benefit in hypoxaemic COPD patients on long-term oxygen therapy. Eur Respir J 1989; 2: 20-5.
96. Kampelmacher MJ, Deenstra M, Van Kesteren RG, Melissant CF, Douze JM, Lammers JW. Transtracheal oxygen therapy: an effective and safe alternative to nasal oxygen administration. Eur Respir J 1997; 10(4): 828-33.
97. Donner CF, Pesce L, Zaccaria S, Erbetta M, Mazzetti D. Organization of respiratory home care in Italy. Monaldi Arch Chest Dis 1993; 48: 468-72.
98. Lock SH, Blower G, Prynne M, Wedzicha JA. Comparison of liquid and gaseous oxygen for domiciliary portable use. Thorax 1992; 47(2): 98-100.
99. Dubois P, Jamart J, Machiels J, Smeets F, Lulling J. Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. Chest 1994; 105: 469-74.
100. Foucher P, Baudouin N, Merati M, Pitard A, Bonniaud P, Reybet-Degat O, Jeannin L. Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 1998; 113: 1580-7.
101. Hjalmarsen A, Melbye H, Wilsgaard T, Holmboe JH, Opdahl R, Viitanen M. Prognosis for chronic obstructive pulmonary disease patients who receive long-term oxygen therapy Int J Tuberc Lung Dis 1999; 3: 1120-6
102. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154(4 Pt 1): 959-67.
103. Eriksen N, Hansen EF, Munch EP, Rasmussen FV, Vestbo J. Chronic obstructive pulmonary disease - admission and prognosis. Ugeskr Laeger 2003; 165(37): 3499-3502 (in Danish).
104. Bongard JP, Pahud C, De Haller R. Insufficient oxygen concentration obtained at domiciliary controls of eighteen concentrators. Eur Respir J 1989; 2: 280-2.
105. Johns DP, Rochford PD, Streeton JA. Evaluation of six oxygen concentrators. Thorax 1985; 40: 806-10.
106. Dheda K, Lim K, Ollivere B, Leftley J, Lampe FC, Salisbury A, Dilworth JP, Rajakulasingam RK. Assessments for oxygen therapy in COPD: are we under correcting arterial oxygen tensions? Eur Respir J 2004; 24(6): 954-7.
107. Walshaw MJ, Lim R, Evans CC, Hind CR. Factors influencing the compliance of patients using oxygen concentrators for long-term home oxygen therapy. Respir Med 1990: 84: 331-3.
108. Sivakumaran P, Garrett JE. The prescription of domiciliary long-term oxygen therapy in Auckland. N Z Med J 1996; 109: 439-42.
109. Bay-Nielsen M, Kehlet H, Strand L, Malmstrom J, Andersen FH, Wara P, Juul P, Callesen T for the Danish Hernia Database Collaboration. Quality assessment of 26, 304 herniorrhaphies in Denmark: a prospective national-wide study. Lancet 2001; 358: 1124-8.
110. Crockett AJ, Moss JR, Cranston JM, Alpers JH. The effect of home oxygen therapy on hospital admission rates in chronic obstructive airways disease. Monaldi Arch Chest Dis 1993; 48(4): 445-6.
111. Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest 1975; 68: 486-92.
112. Buyse B, Demedts M. Long-term oxygen therapy with concentrators and liquid oxygen. Acta Clin Belg 1995; 50(3): 149-57.
113. Petty TL. Historical perspective on long-term oxygen therapy. In: Walter O'Donohue Jr WJ, editor. Long-term oxygen therapy. Scientific basis and clinical application. Dekker, 1995: 1-23.
114. Timms RM, Khaja FU, Williams GW, and the Nocturnal Oxygen Therapy Trial Group. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann Intern Med 1985; 102: 29-36.
115. Zielinski J, Tobiasz M, Hawrylkiewicz I, Sliwinski P, Palasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998; 113: 65-70.
116. Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752-8.
117. Petty TL, Bliss PL. Ambulatory oxygen therapy, exercise, and survival with advanced chronic obstructive pulmonary disease (the Nocturnal Oxygen Therapy Trial revisited). Respir Care 2000; 45: 204-13.
118. Anto JM, Vermeire P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001; 17 (5): 982-94.
119. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350(10): 1005-12.
120. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167(4): 544-9.
121. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J, Anto JM. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 2001; 164(6): 1002-7.
122. 1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 1989; 2 (8): 710-5.
123. Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 1995: 107: 1193-8.
124. Dallari R, Barozzi G, Pinelli G, Merighi V, Grandi P, Manzotti M, Tartoni PL. Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration 1994; 61: 8-13.
125. Klein G, Ruhle KH, Matthys H. Long-term oxygen therapy vs. IPPB therapy in patients with COLD and respiratory insufficiency: survival and pulmonary hemodynamics. Eur J Respir Dis Suppl 1986; 146: 409-15.
126. Miyamoto K, Aida A, Nishimura M, Aiba M, Kira S, Kawakami Y. Gender effect on prognosis of patients receiving long-term home oxygen therapy. The Respiratory Failure Research Group in Japan. Am J Respir Crit Care Med 1995; 152(3): 972-6.
127. Keller R, Ragaz A, Borer P. Predictors for early mortality in patients with long-term oxygen home therapy. Respiration 1985; 48(3): 216-21.
128. Skwarski K, MacNee W, Wraith PK, Sliwinski P, Zielinski J. Predictors of survival in patients with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Chest 1991; 100(6): 152-7.
129. Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax 1987; 42: 105-10.
130. Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC. Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice. Eur Respir J 2002; 20: 819-25.
131. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 580-4.
132. Groenewegen KH, Schols AMWJ, Wouter EFM. Mortality and mortality-related factors after hospitalisation for acute exacerbation of COPD. Chest 2003; 124: 459-67.
133. Schols AMWJ, Wesseling G, Kester ADM, de Vries G, Mostert R, Slangen J, Wouters EF. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001; 17: 337-42.
134. Braun SR, Dixon RM, Keim NL, Luby M, Anderegg A, Shrago ES. Predictive clinical value of nutritional assessment factors in COPD. Chest 1984; 85: 353-7.
135. Pouw EM, Ten Velde GPM, Croonen BHPM, Kester AD, Schols AM, Wouters EF. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin Nutr 2000; 19: 95-9.
136. Calverley PMA. Supplemental oxygen therapy in COPD: is it really useful? Thorax 2000; 55: 537-8.
137. O'Donohue WJ Jr. Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest 1995; 107: 301-2.
138. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe J, Rudkin S, Whyte K. Ambulatory oxygen improves quality of life of COPD patients: a randomized controlled study. Eur Respir J 2002; 20: 306-12.
139. Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J 1996; 9: 2335-9.
140. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation. Monaldi Arch Chest Dis 1999; 54: 193-6.